Literature DB >> 19424570

Regulatory T cells actively infiltrate metastatic brain tumors.

Adam Quasar Sugihara1, Cleo E Rolle, Maciej S Lesniak.   

Abstract

Regulatory T cells (CD4+CD25+FoxP3+, Treg) have been shown to play a major role in suppression of the immune response to malignant gliomas. In this study, we investigated the kinetics of Treg infiltration in metastatic brain tumor models, including melanoma, breast and colon cancers. Our data indicate that both CD4+ and Treg infiltration are significantly increased throughout the time of metastatic tumor progression. These findings were recapitulated in human CNS tumor samples of metastatic melanoma and non-small cell lung carcinoma. Collectively, these data support investigating immunotherapeutic strategies targeting Treg in metastatic CNS tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424570     DOI: 10.3892/ijo_00000282

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  22 in total

Review 1.  A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis.

Authors:  Hila Doron; Tobias Pukrop; Neta Erez
Journal:  Cancer Res       Date:  2019-01-24       Impact factor: 12.701

Review 2.  Embracing rejection: Immunologic trends in brain metastasis.

Authors:  S Harrison Farber; Vadim Tsvankin; Jessica L Narloch; Grace J Kim; April K S Salama; Gordana Vlahovic; Kimberly L Blackwell; John P Kirkpatrick; Peter E Fecci
Journal:  Oncoimmunology       Date:  2016-04-11       Impact factor: 8.110

Review 3.  Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases.

Authors:  Imola Wilhelm; Csilla Fazakas; Kinga Molnár; Attila G Végh; János Haskó; István A Krizbai
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-18       Impact factor: 6.200

Review 4.  Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses.

Authors:  Arya Biragyn; Dan L Longo
Journal:  Semin Cancer Biol       Date:  2012-01-12       Impact factor: 15.707

5.  T-cell TGF-β signaling abrogation restricts medulloblastoma progression.

Authors:  David Gate; Moise Danielpour; Javier Rodriguez; Gi-Bum Kim; Rachelle Levy; Serguei Bannykh; Joshua J Breunig; Susan M Kaech; Richard A Flavell; Terrence Town
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-31       Impact factor: 11.205

Review 6.  The central role of hypothalamic inflammation in the acute illness response and cachexia.

Authors:  Kevin G Burfeind; Katherine A Michaelis; Daniel L Marks
Journal:  Semin Cell Dev Biol       Date:  2015-11-03       Impact factor: 7.727

7.  Tregs utilize beta-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation.

Authors:  Dolgor Baatar; Purevdorj B Olkhanud; Valerie Wells; Fred E Indig; Livio Mallucci; Arya Biragyn
Journal:  Brain Behav Immun       Date:  2009-06-09       Impact factor: 7.217

Review 8.  Brain immunology and immunotherapy in brain tumours.

Authors:  John H Sampson; Michael D Gunn; Peter E Fecci; David M Ashley
Journal:  Nat Rev Cancer       Date:  2019-12-05       Impact factor: 60.716

Review 9.  A review of glioblastoma immunotherapy.

Authors:  Ravi Medikonda; Gavin Dunn; Maryam Rahman; Peter Fecci; Michael Lim
Journal:  J Neurooncol       Date:  2020-04-06       Impact factor: 4.130

10.  Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model.

Authors:  Sadhak Sengupta; Suvobroto Nandi; Enal S Hindi; Derek A Wainwright; Yu Han; Maciej S Lesniak
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.